Our Leadership Team

Lee Patterson CEO

Lee Patterson

Chief Executive Officer

Lee specialises in steering preclinical CROs to implement robust and effective plans for long-term commercial growth.

Rob Kirby PhD

Chief Operating Officer

Rob is a skilled pharmacologist with over 10 years’ experience in ion channel drug discovery.

Clare Rutty

Chief Financial Officer

Clare is an experienced CIMA qualified Accountant and completed a degree in Mathematics and Statistics...

Eddy Stevens PhD

Chief Scientific Officer

Dr Edward Stevens has over 20 years’ experience in ion channel drug discovery.

Gary Clark PhD

Director, Screening Technologies

Gary has over 20 years of ion channel Drug Discovery experience with 14 years in the contract research arena.

Tony Rush PhD

Director, Neuroscience

Tony has been in the ion channel field for over 25 years across academia and industry and is widely published.

Chris Mathes PhD MBA

Chief Commercial Officer

Chris Mathes has more than 25 years of experience in the biopharmaceutical industry, focused on pre-clinical CRO leadership, sales and marketing.

Steve Jenkinson PhD

VP, Drug Discovery and Safety Assessment, USA

Steve has over 25 years experience leading discovery projects. He is a thought leader in his field with a strong background in drug discovery and secondary pharmacology.

John Ridley PhD

Director of Commercial Operations

John has been working in the ion channel field for over 20 years.

Sophie Rose PhD

Head of Business Development, Europe

Sophie has a PhD in Chemistry. She joined Metrion in 2018 and is responsible for sales and business development in the UK and Europe.

Sue Peffer

Head of Marketing

Sue is a hands-on marketing leader who manages Metrion's global marketing operations.

Metrion Biosciences is a contract research organisation (CRO) specialising in high-quality preclinical drug discovery services.
magnifier
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram